title: Distal right ventricular coil position reduces defibrillation thresholds.
abstract: Distal RV Coil Position Reduces DFTs.
  
  
  BACKGROUND
  Understanding the factors that affect defibrillation thresholds (DFTs) has important implications both for optimization of defibrillation efficacy and for the design of new transvenous leads. The aim of this prospective study was to test the hypothesis that defibrillation efficacy is improved with the right ventricular (RV) coil in a distal position compared with a more proximal RV coil position.
  
  
  RESULTS
  A novel defibrillation lead with three adjacent RV defibrillation coils (distal 0.8 cm, middle 3.7 cm, proximal 0.8 cm) was used for this study to permit comparison of DFTs with the proximal and distal RV coil positions without lead repositioning. In the distal RV configuration, the distal and middle RV coils were connected electrically as the anode for defibrillation. In the proximal RV configuration, the middle and proximal coils were the anode. A superior vena cava (SVC) coil and active can were connected electrically as the cathode (reversed polarity, RV-->Can+SVC). In each patient, the DFT was measured twice using a binary search protocol with the distal RV and proximal RV configurations, with the order of testing randomized. The study cohort consisted of 31 subjects (mean age 65 +/- 12 years, mean left ventricular ejection fraction 30% +/- 16%, 81% male predominance). The mean delivered energy (8.2 +/- 5.3 J vs 11.2 +/- 6.1 J), leading-edge voltage (335 +/- 109 V vs 393 +/- 118 V), and peak current (11.6 +/- 5.2 A vs 14.9 +/- 7.3 A) at DFT all were significantly lower with the distal RV configuration compared to the proximal RV configuration (P < 0.01 for all comparisons).
  
  
  CONCLUSIONS
  DFTs are significantly reduced with the distal RV configuration compared to the proximal RV configuration. Defibrillation leads should be designed with the shortest tip to coil distance that can be achieved without compromising ventricular fibrillation sensing.
authors.affiliation: Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland, USA. erashba@medicine.umaryland.edu
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Rashba
authors.forename: Matt
authors.initials: M
authors.lastname: Bonner
authors.forename: John
authors.initials: J
authors.lastname: Wilson
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Shorofsky
authors.forename: Robert W
authors.initials: RW
authors.lastname: Peters
authors.forename: Michael R
authors.initials: MR
authors.lastname: Gold
mesh_terms: D000368:Aged; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000628:therapy; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D015331:Cohort Studies; D017147:Defibrillators, Implantable; D004056:Differential Threshold; D005260:Female; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000175:diagnosis / Q000628:therapy*